Arteriosclerotic Vascular Disease — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for arteriosclerotic vascular disease. 15 active patents protecting 2 drugs from 2+ originators. First major cliff: 2037. Daily refresh.

2
Approved drugs
15
Active US patents
66/100
Avg vulnerability
—
Annual revenue covered

Originators in Arteriosclerotic Vascular Disease

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Merck & Co. 10 patents Pfizer 5 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating arteriosclerotic vascular disease. Each bar = one year. Y-axis scaled to peak year (6 patents).

6
26
2
27
2
30
5
37

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Zocor
simvastatin
 Merck & Co. 10 70 — 2026-10-11
Lipitor
Atorvastatin Calcium
 Pfizer 5 61 — 2037-06-07

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
7326708 Zocor other 80 2026-10-11
7326708 Zocor other 80 2026-10-11
7326708 Zocor other 80 2026-10-11
7326708 Zocor other 80 2026-10-11
7326708 Zocor other 80 2026-10-11
7326708 Zocor other 80 2026-10-11
11925704 Lipitor method of use 75 2037-06-07
11654106 Lipitor method of use 70 2037-06-07
10300041 Zocor formulation 60 2027-04-26
10300041 Zocor formulation 60 2027-04-26

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
9597289 Zocor formulation 48 2030-02-23
9597289 Zocor formulation 48 2030-02-23
11369567 Lipitor formulation 50 2037-06-07
12370136 Lipitor formulation 55 2037-06-07
12168069 Lipitor formulation 55 2037-06-07
10300041 Zocor formulation 60 2027-04-26
10300041 Zocor formulation 60 2027-04-26
11654106 Lipitor method of use 70 2037-06-07
11925704 Lipitor method of use 75 2037-06-07
7326708 Zocor other 80 2026-10-11

Related